Search
for
Sort by
Research 271–300 of 456
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- Farmácia dos Clérigos - Porto e nos Serviços Farmacêuticos da University College Hospital - Londres, Reino Unido, ao abrigo do programa Erasmus+
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Uso de cetrizina en alopecia androgenética
- Part Three (Cure Most Diseases by Logical Nutrition Treatment): The Society Agent Simulating (SAS) & Usage of Oral and Dental Diseases to Predict Criminals Earlier
- Vitamin B-Complex and its Relationship with the Health of Vegetarian People
- Practical Approach for Treatment lines of Alopecia Areata: Review Article
- Uso de corticoides no tratamento da Alopecia Areata
- Hair Changes due to Drugs
- Alopecia Areata
- Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Dermatological drugs, topical agents, and cosmetics
- Classified Advertising
- Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata
- The eyelash follicle features and anomalies: A review
- LC–MS bioanalytical method for simultaneous determination of latanoprost and minoxidil in the skin
- Characteristics of Malassezia furfur at various pH and effects of Malassezia lipids on skin cells
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Ether: Fiction or Reality? A Review
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Ageing weller
- A novel microparticle based formulation for topical delivery of FOL-005, a small peptide
- Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study
- Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution.
- Bimatoprost
- Editor’s Picks June 2025
- 6525 Alternating Hypothyroidism and Hyperthyroidism Complicated by Thyroid Eye Disease
- MON-594 Alternating Hypothyroidism and Hyperthyroidism Complicated by Thyroid Eye Disease
- Spanlastic-laden nanogel as a plausible platform for dermal delivery of bimatoprost with superior cutaneous deposition and hair regrowth efficiency in androgenic alopecia